[1] Vuković T, Kuek L E, Yu B, et al. The therapeutic landscape of citrin deficiency[J]. J Inherit Metab Dis, 2024, 47(6): 1157-1174.
[2] Hayasaka K. Pathogenesis and management of citrin deficiency[J]. Intern Med, 2024, 63(14): 1977-1986.
[3] Saheki T, Moriyama M, Funahashi A, et al. AGC2 (Citrin) deficiency—from recognition of the disease till construction of therapeutic procedures[J]. Biomolecules, 2020, 10(8): 1100.
[4] 中国医师协会医学遗传医师分会临床生化专业委员会, 中华医学会儿科学分会内分泌遗传代谢学组, 中国妇幼保健协会儿童疾病和保健分会遗传代谢学组, 等. 中国尿素循环障碍诊断治疗和管理指南[J]. 中华儿科杂志, 2022, 60(11): 1118-1126.
[5] Michiharu K, Naoki T, Takefumi K, et al. Citrin deficiency: clinical and nutritional features[J]. Nutrients, 2023, 15(10): 2284.
[6] Yoshiyuki O, Miki O, Masahide Y, et al. Analysis of daily energy, protein, fat, and carbohydrate intake in citrin-deficient patients: towards prevention of adult-onset type Ⅱ citrullinemia[J]. Molecular Genetics and Metabolism, 2021, 133(1): 63-70.
[7] Risinger M, Kalfa T A. Red cell membrane disorders: structure meets function[J]. Blood, 2020, 136(11): 1250-1261.
[8] 刘旭, 李园, 赵馨, 等. 遗传性椭圆形红细胞增多症患者临床及基因突变特征:9例报告及文献复习[J]. 中华血液学杂志, 2023, 44(4): 316-320.
[9] Gallagher P G. Hereditary elliptocytosis: spectrin and protein 4.1R[J]. Semin Hematol, 2004, 41(2): 142-164. |
